Article Text

See original article:

Download PDFPDF
Statins for heart failure: at the crossroads between cholesterol reduction and pleiotropism?
  1. S von Haehling,
  2. S D Anker*
  1. National Heart & Lung Institute, Department of Clinical Cardiology, Imperial College School of Medicine, London, UK
  1. Correspondence to:
    Dr Stephan von Haehling
    National Heart & Lung Institute, Department of Clinical Cardiology, Dovehouse Street, London SW3 6LY, UK; s.vonhaehlingimperial.ac.uk

Abstract

Statins are being hailed as the new aspirin—but are they beneficial for patients with heart failure?

  • CORONA, controlled rosuvastatin multinational trial in heart failure
  • CRP, C reactive protein
  • FDA, Food and Drug Administration
  • GISSI-HF, Gruppo Italiano per lo studio della sopravvivenza nell’insufficienza cardiaca
  • HMG-CoA, 3-hydroxy-3-methylglutaryl-coenzyme A
  • PUFA, polyunsaturated fatty acids
  • heart failure
  • statins

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • * Also at the Division of Applied Cachexia Research, Department of Cardiology, Charité Medical School, Campus Virchow-Klinikum, Berlin, Germany

Linked Articles

  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society
  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society
  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society
  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society
  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society
  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society
  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society
  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society
  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society
  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society
  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society
  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society
  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society
  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society
  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society
  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society
  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society
  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society
  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society